The multicenter, phase II prospective study of paclitaxel plus capecitabine as first-line chemotherapy in advanced gastric carcinoma

Oncologist

Volumn 19, Issue 2, 2014, Pages 173-174

  Gong, Jifang ^a   Hu, Bing ^b   Zhang, Xiaotian ^a   Zhang, Fengchun ^c   Zhang, Jun ^d   Xu, Nong ^e   Fan, Qingxia ^f   Bai, Yuxian ^g   Jiao, Shunchang ^h   Wang, Jinwan ⁱ   Bai, Chunmei ^j   Zheng, Leizhen ^k   Shi, Yingqiang ^l   Liu, Yunpeng ^m   Liang, Jun ⁿ   Hu, Guoqing ^o   Cheng, Ying ^p   Xu, Ruihua ^q   Bai, Yu ^r   Shen, Lin ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

^c Suzhou Kowloon Hospital Affiliated with Shanghai Jiao Tong University School of Medicine   (China)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^e ZHEJIANG UNIVERSITY   (China)

^f THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^g HARBIN MEDICAL UNIVERSITY   (China)

^h 301th Hospital of the Chinese People's Liberation Army   (China)

ⁱ CANCER HOSPITAL   (China)

^j PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^k SHANGHAI JIAO TONG UNIVERSITY   (China)

^l FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^m CHINA MEDICAL UNIVERSITY   (China)

ⁿ QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^o HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^p JILIN PROVINCIAL CANCER HOSPITAL   (China)

^q SUN YAT SEN UNIVERSITY   (China)

^r PEKING UNIVERSITY FIRST HOSPITAL   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; PACLITAXEL; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; FLUOROURACIL;

ALOPECIA; ARTICLE; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FOLLOW UP; HAND FOOT SYNDROME; HUMAN; LEUKOPENIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; STOMACH CARCINOMA; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; MALE; PATHOLOGY; PROSPECTIVE STUDY; STOMACH NEOPLASMS; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MALE; PACLITAXEL; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84894084708     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0137     Document Type: Article

References (0)